ACELYRIN, INC. - Common Stock (SLRN)
2.5000
-0.1900 (-7.06%)
Acelyrin Inc is a biopharmaceutical company focused on developing innovative therapies for patients with chronic and debilitating conditions
The company specializes in advancing treatments that target unmet medical needs, with particular emphasis on autoimmune and inflammatory diseases. Through its robust pipeline, Acelyrin aims to improve the quality of life for patients by harnessing cutting-edge science and technology to create effective and safe therapeutic options. The organization is committed to rigorous clinical research and collaboration with healthcare professionals to bring new solutions to the market.
Date | Open | High | Low | Close | Volume | Adjusted Close |
---|---|---|---|---|---|---|
3/03/2025 | 2.70 | 2.74 | 2.67 | 2.69 | 1,797,582 | 2.69 |
2/28/2025 | 2.57 | 2.71 | 2.56 | 2.68 | 1,628,376 | 2.68 |
2/27/2025 | 2.56 | 2.60 | 2.52 | 2.56 | 2,375,452 | 2.56 |
2/26/2025 | 2.58 | 2.65 | 2.54 | 2.60 | 2,398,586 | 2.60 |
2/25/2025 | 2.59 | 2.65 | 2.50 | 2.57 | 3,322,531 | 2.57 |
2/24/2025 | 2.60 | 2.65 | 2.56 | 2.58 | 6,093,130 | 2.58 |
2/21/2025 | 2.56 | 2.64 | 2.37 | 2.60 | 12,571,626 | 2.60 |
2/20/2025 | 2.15 | 2.20 | 2.14 | 2.17 | 2,757,505 | 2.17 |
2/19/2025 | 2.12 | 2.17 | 2.08 | 2.15 | 1,916,663 | 2.15 |
2/18/2025 | 2.16 | 2.18 | 2.11 | 2.13 | 2,334,606 | 2.13 |
2/14/2025 | 2.05 | 2.14 | 2.05 | 2.13 | 2,335,984 | 2.13 |
2/13/2025 | 2.01 | 2.10 | 2.00 | 2.06 | 5,645,952 | 2.06 |
2/12/2025 | 2.02 | 2.06 | 2.00 | 2.00 | 1,581,818 | 2.00 |
2/11/2025 | 1.90 | 2.05 | 1.84 | 2.03 | 3,374,477 | 2.03 |
2/10/2025 | 2.06 | 2.06 | 1.89 | 1.89 | 5,209,194 | 1.89 |
2/07/2025 | 2.02 | 2.28 | 1.95 | 2.04 | 16,473,804 | 2.04 |
2/06/2025 | 1.94 | 1.94 | 1.87 | 1.90 | 2,593,043 | 1.90 |
2/05/2025 | 1.89 | 1.95 | 1.85 | 1.94 | 536,136 | 1.94 |
2/04/2025 | 1.91 | 1.95 | 1.88 | 1.89 | 507,452 | 1.89 |
2/03/2025 | 1.92 | 1.95 | 1.85 | 1.92 | 776,602 | 1.92 |
1/31/2025 | 2.02 | 2.04 | 1.91 | 1.97 | 676,492 | 1.97 |
1/30/2025 | 1.95 | 2.05 | 1.91 | 1.98 | 1,230,783 | 1.98 |
1/29/2025 | 1.97 | 1.97 | 1.89 | 1.91 | 712,992 | 1.91 |
1/28/2025 | 1.96 | 2.00 | 1.90 | 1.97 | 874,266 | 1.97 |
1/27/2025 | 1.96 | 2.05 | 1.92 | 1.96 | 1,359,237 | 1.96 |
1/24/2025 | 1.94 | 2.01 | 1.91 | 1.98 | 774,497 | 1.98 |
1/23/2025 | 2.02 | 2.05 | 1.93 | 1.96 | 1,030,675 | 1.96 |
1/22/2025 | 1.99 | 2.06 | 1.94 | 2.02 | 1,058,171 | 2.02 |
1/21/2025 | 2.02 | 2.03 | 1.91 | 1.99 | 750,084 | 1.99 |
1/17/2025 | 2.01 | 2.04 | 1.92 | 1.99 | 766,567 | 1.99 |
1/16/2025 | 2.02 | 2.08 | 1.93 | 1.99 | 1,249,981 | 1.99 |
1/15/2025 | 2.15 | 2.16 | 2.00 | 2.02 | 1,115,438 | 2.02 |
1/14/2025 | 2.19 | 2.19 | 2.02 | 2.10 | 792,102 | 2.10 |
1/13/2025 | 2.03 | 2.17 | 1.96 | 2.15 | 1,427,660 | 2.15 |
1/10/2025 | 2.08 | 2.15 | 2.02 | 2.06 | 1,437,394 | 2.06 |
1/08/2025 | 2.18 | 2.35 | 2.00 | 2.14 | 4,441,718 | 2.14 |
1/07/2025 | 2.15 | 2.39 | 1.91 | 2.20 | 11,555,055 | 2.20 |
1/06/2025 | 3.85 | 3.89 | 3.38 | 3.49 | 2,078,004 | 3.49 |
1/03/2025 | 3.51 | 3.95 | 3.51 | 3.82 | 1,459,585 | 3.82 |
1/02/2025 | 3.18 | 3.41 | 3.09 | 3.30 | 469,287 | 3.30 |
12/31/2024 | 3.08 | 0.00 | 3.14 | 3.14 | 0 | 3.14 |
12/30/2024 | 3.20 | 3.30 | 3.05 | 3.08 | 511,414 | 3.08 |
12/27/2024 | 3.26 | 3.40 | 3.17 | 3.25 | 508,168 | 3.25 |
12/26/2024 | 3.16 | 3.34 | 3.10 | 3.32 | 376,772 | 3.32 |
12/24/2024 | 3.20 | 3.21 | 3.06 | 3.17 | 244,221 | 3.17 |
12/23/2024 | 3.15 | 3.21 | 3.08 | 3.18 | 517,120 | 3.18 |
12/20/2024 | 3.18 | 3.25 | 3.10 | 3.15 | 956,105 | 3.15 |
12/19/2024 | 3.32 | 3.41 | 3.11 | 3.21 | 704,883 | 3.21 |
12/18/2024 | 3.54 | 3.60 | 3.14 | 3.27 | 1,087,519 | 3.27 |
12/17/2024 | 3.34 | 3.51 | 3.26 | 3.50 | 697,764 | 3.50 |
12/16/2024 | 3.24 | 3.47 | 3.14 | 3.37 | 977,783 | 3.37 |
12/13/2024 | 3.49 | 3.49 | 3.14 | 3.23 | 785,915 | 3.23 |
12/12/2024 | 3.49 | 3.73 | 3.38 | 3.54 | 1,469,021 | 3.54 |
12/11/2024 | 3.38 | 3.76 | 3.18 | 3.41 | 3,269,312 | 3.41 |
12/10/2024 | 4.30 | 4.31 | 4.03 | 4.06 | 1,032,421 | 4.06 |
12/09/2024 | 4.27 | 4.46 | 4.25 | 4.29 | 360,501 | 4.29 |
12/06/2024 | 4.25 | 4.40 | 4.22 | 4.25 | 470,294 | 4.25 |
12/05/2024 | 4.22 | 4.31 | 4.11 | 4.21 | 485,792 | 4.21 |